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Abstract
Four members of the annexin family, herein referred to as max (for medaka annexin) 1^4, have recently been identified
through hybridization cloning in the killifish Oryzias latipes (D. Osterloh, J. Wittbrodt and V. Gerke, Characterization and
developmentally regulated expression of four annexins in the killifish medaka. DNA and Cell Biol., in press). These annexins
which are expressed in a developmentally regulated manner are present as a maternal pool in unfertilized eggs of another fish
species, Misgurnus fossilis, and it has been proposed that they play a role in the Ca2-regulated exocytosis of cortical granules
occurring after fertilization. To characterize biochemical properties of the medaka proteins possibly relevant to their function
in early development, we analyzed the ability of recombinantly expressed max 1^4 to interact with the principal structures of
the egg cortex, phospholipid membranes and actin filaments. We show that all medaka annexins bind to acidic phospholipids
in a Ca2-regulated manner, although exhibiting different Ca2 sensitivities. All medaka annexins, but max 1, are also
capable of inducing, in a Ca2-dependent manner, phospholipid vesicle aggregation, albeit only max 3 displays this activity at
Ca2 concentrations met in stimulated (i.e. fertilized) eggs. Max 3 is also the only medaka annexin able to interact with F-
actin in the presence of Ca2. These data identify by biochemical criteria max 3 as a close relative of the mammalian annexins
I and II, thus supporting previous sequence-based comparisons. Max 3 is therefore the prime annexin candidate for being
involved in cortical granule exocytosis, possibly by providing granule^granule, granule^plasma membrane and/or granule^
cytoskeleton contacts. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
The initiation of developmental processes in the
eggs of many species is thought to be triggered by
transient increases in the level of cytoplasmic free
Ca2 initiated upon fertilization (for a recent review
see [1]). This process has been well documented in
¢sh eggs where a Ca2 wave with a peak value of up
to 30 WM transverses the egg cytoplasm in a narrow
band starting at the site of sperm entry, the animal
pole [2]. The transient Ca2 increase triggers the cor-
tex reaction, i.e. the exocytosis of cortical granules
and thus the assembly of the fertilization envelope
(for review see [1,3]). While this process has been
described phenomenologically, the molecular events
underlying the egg’s response to changes in free cy-
tosolic Ca2 are not well understood. Based on our
knowledge of other Ca2-regulated processes Ca2-
binding proteins activated by the Ca2 transients are
likely to play a role in the stimulus^response cou-
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pling. One candidate is protein kinase C which ap-
pears to be involved in triggering amphibian and
mammalian development [4,5]. A number of other
Ca2-binding proteins have also been identi¢ed in
unfertilized ¢sh eggs and thus are potentially in-
volved in the processes described above. These in-
clude two members of the EF hand superfamily
(calmodulin as well as a homolog of the mammalian
S100A1) and several annexins [6,7].
Annexins are Ca2- and phospholipid-binding pro-
teins implicated in a wide range of membrane related
events [8^10]. These include Ca2-triggered exocyto-
sis [11^13] and it has been proposed that oocyte an-
nexins could participate in the Ca2-regulated events
leading to cortical granule exocytosis. A combined
biochemical/immunological approach has indeed re-
vealed the presence of ¢ve di¡erent annexins in un-
fertilized eggs of the fresh-water ¢sh Misgurnus fos-
silis [7]. Four of these ¢ve annexins have recently
been cloned from the medaka ¢sh Oryzias latipes
and named max (for medaka annexin) 1^4. Their
sequences were shown to meet the criteria of the
typical two domain annexin structure characterized
by the presence of a conserved protein core and a
unique N-terminal domain [14]. Detailed sequence
comparisons indicate that two medaka annexins
(max 1 and 2) are highly similar in sequence to mam-
malian annexins V and IV, respectively, whereas max
3 and 4 are probably novel members of the family
most closely related to mammalian annexins I or II
and XI, respectively. While the annexins present in
unfertilized eggs represent a maternal pool, max 1^4
are also newly synthesized during ¢sh development.
Their embryonic expression is strictly controlled at
the temporal and spatial level with the developing
digestive tract being the prime region of max 1^3
expression during somitogenesis and the mesendo-
derm of the anterior prechordal plate of neurula em-
bryos showing speci¢c max 4 expression [14].
To analyze whether the medaka annexins are ca-
pable of participating in any of the Ca2-regulated
processes accompanying the cortex reaction, we per-
formed a biochemical analysis concentrating on
interactions with phospholipids and cytoskeletal
structures. Medaka annexins were expressed recom-
binantly in bacteria, puri¢ed and subjected to Ca2-
dependent phospholipid and F-actin binding as
well as vesicle aggregation studies. The results show
that of the four medaka annexins, only max 3 is
capable of binding to phospholipids to a signi¢cant
extent at Ca2 concentrations reached in eggs follow-
ing fertilization. In addition to binding to phospho-
lipids, max 3 is also able to aggregate membrane
vesicles, thus displaying a property possibly required
for the docking of cortical granules to one another or
to the egg plasma membrane.
2. Materials and methods
2.1. Construction of expression vectors
cDNAs encoding the previously cloned medaka
annexins max 1^4 [14] were ampli¢ed by PCR using
the oligonucleotides shown below to introduce suit-
able restriction sites (marked in capital letters):
max 1 3P-oligo cgcgATGCATttactcgcctccgcacagttccga
5P-oligo gcgcGAATTCaatggcagccatcggaaaccgtgga
max 2 3P-oligo cgctGTCGACtggttacgcgtcatcacccccac
5P-oligo cgcgaGAATTCaaatggctagcaaaggaaccgtg
max 3 3P-oligo cgcgATGCATtgacgcaaatttagttatctcctcc
5P-oligo ggtaGAATTCcatgtctttcatccaagccttcctg
max 4 3P-oligo gtcctGTCGACaacagttgcagctccggtctagtcac
5P-oligo gcagcGAATTCagatgagttacccaggctacccccca.
The puri¢ed PCR products were digested with the
respective restriction enzymes and then cloned into a
modi¢ed pET 23 a (+) vector which directs the ex-
pression of native full-length protein without a pre-
ceding T7-tag [15].
2.2. Expression and puri¢cation of max 1^4
Expression of the recombinant proteins was car-
ried out in BL21(DE3)pLysS bacteria in LB contain-
ing 150 Wg/ml ampicillin and 35 Wg/ml chloramphe-
nicol. Transformed bacteria were grown at 30‡C to
an OD600 of 0.6 and recombinant protein expression
was then induced by IPTG. The bacteria were grown
for 4 h, then pelleted at 4000Ug, resuspended in 1/10
culture volume of bu¡er A (50 mM Tris-HCl pH 7.5,
150 mM NaCl, 1 mM DTT, 1 mM EGTA, 0.5 mM
PMSF) and lyzed by 3 freeze/thawing cycles and
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sonication (3U30 s). Insoluble proteins were sepa-
rated by centrifugation at 30,000Ug for 30 min.
Max 1, 2 and 3 were present as soluble proteins in
the supernatants whereas max 4 was insoluble.
Bacterial extracts containing the soluble max 1^3
were dialyzed against bu¡er D for further puri¢ca-
tion (20 mM imidazole-HCl pH 7.4, 10 mM NaCl,
1 mM DTT, 1 mM EGTA, 0.5 mM PMSF). For
puri¢cation of max 4, the insoluble bacterial pellet
was washed with bu¡ers W1 (bu¡er D containing 1%
sodium deoxochelate) and W2 (bu¡er D containing
1% sodium deoxochelate and 1% Nonidet P-40) and
then solubilized in bu¡er U (20 mM imidazole-HCl
pH 7.4, 8 M urea, 100 mM NaCl). Subsequently,
proteins present in the urea extract were renatured
by stepwise dilution with and dialysis against bu¡er
D. The solution was cleared by centrifugation and
dialysis against bu¡er D was continued. All dialyzed
max proteins were subjected to ion exchange chro-
matography using DEAE cellulose DE-52. Using
bu¡er D as column bu¡er max 1, 3 and 4 did not
bind to the matrix, whereas max 2 was bound and
was eluted using 75 mM NaCl in bu¡er D. The £ow-
through fractions containing max 3 and 4 were dia-
lyzed against bu¡er S (10 mM picolinic acid pH 5.3,
10 mM NaCl, 1 mM DTT, 1 mM EGTA, 0.5 mM
PMSF) and applied to a S10-HyperD column equi-
librated in the same bu¡er. Both proteins bound to
the resin and were eluted using a linear NaCl gra-
dient in du¡er S. Max 3 and 4 were released at 150
and 180 mM NaCl, respectively. The £ow-through
fraction of the DE-52 column containing max 1
and the max 2 pool eluted from the DE-52 column
were dialyzed against bu¡er Q (10 mM diethanol
amine pH 8.8, 10 mM NaCl, 1 mM DTT, 1 mM
EGTA), bound to a Q10-HyperD column equili-
brated in the same bu¡er and eluted using a linear
NaCl gradient in bu¡er Q. Max 1 and 2 eluted at 210
and 280 mM NaCl, respectively. Following ion-ex-
change chromatography the fractions containing the
di¡erent medaka annexins were dialyzed individually
against bu¡er D containing 1 mM L-3-trans-carboxy-
oxiran-2-carbonyl-L-leucyl-agmantin (E64, Biomol)
and 1 mM CaCl2 instead of 1 mM EGTA and bound
to phospholipid vesicles (see Section 2.3). The lipo-
somes were pelleted by centrifugation (200 000Ug for
15 min) and washed several times with bu¡er con-
taining 1 mM E64 and 1 mM CaCl2. Bound annexins
were then eluted by resuspending the liposomes in
EGTA-containing bu¡er D and separating the re-
leased proteins from the lipid vesicles by centrifuga-
tion. For storage and further analysis, max 1^4 were
dialyzed against bu¡er ST (25 mM imidazole-HCl
pH 7.4, 150 mM NaCl, 0.5 mM DTT, 1 mM
NaN3, 50 WM EGTA 50% glycerol). Starting with
500 ml of bacterial cultures the protocols described
yield 8, 20, 12 and 7 mg of puri¢ed max 1, 2, 3 and 4,
respectively.
2.3. Liposome binding and vesicle aggregation assays
Brain extract (Folch fraction I from bovine brain:
Sigma B 1502) was dissolved in chloroform (200 mg/
ml), then dried under nitrogen and resuspended in 10
WM EGTA by freeze/thawing. The lipids were pel-
leted by centrifugation (200 000Ug ; 15 min) and re-
suspended in water to yield a concentration of 5 mg/
ml. To ensure unilamellar liposomes of homogeneous
size, the lipid emulsion was passaged repeatedly at
60‡C through a 200 nm pore membrane utilizing the
LiposoFast-Basic system (Avestin). Phospholipid-
binding assays were performed in 100 Wl bu¡er B
(50 mM imidazole-HCl pH 7.4, 150 mM NaCl, 150
WM Na-isocitrate) at di¡erent free Ca2-concentra-
tions adjusted by adding increasing amounts of
CaCl2 from a stock solution to the bu¡er. The free
Ca2 concentrations were calculated using WinMaxc
1.70 with isocitrate as calcium chelator. Amounts of
0.1 nmol of the respective medaka annexin were in-
cubated in bu¡er B with a given Ca2 concentration
for 15 min at 4‡C and then centrifuged at 200 000Ug
for 30 min. Liposomes were added (2 mg/ml) to the
soluble proteins and the reaction mixtures were in-
cubated for 30 min at room temperature and then
spun at 200 000Ug for 30 min. Equivalent amounts
of supernatant and pellet fractions were analyzed by
SDS-PAGE and the proteins present were Coomas-
sie-stained and quanti¢ed densitometrically using a
Hewlett Packard Scanjet 4c/T and NIH-Image.
The aggregation assays were carried out in half-
microcuvettes in 500 Wl bu¡er B containing varying
concentrations of free Ca2 adjusted as described
above. Liposomes of uniform size prepared from bo-
vine brain phospholipids as described above were
added to bu¡er B containing a ¢xed Ca2 concen-
tration to yield an OD at 450 nm of approximately
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0.5 and then incubated for 15 min at room temper-
ature with a recording of the baseline OD450 using a
Beckman DU 640 spectrophotometer. A 1-nmol
amount of the respective medaka annexin was added
and the kinetics of vesicle aggregation were recorded
for 300 s at 450 nm.
2.4. F-actin binding
Skeletal muscle actin (50 Wg) was incubated with
0.1 nmol of the individual max protein in bu¡er P
(100 mM KCl, 2 mM MgCl2, 0.2 mM DTT, 0.1 mM
ATP, 1 mM NaN3, 10 mM imidazole-HCl pH 7.4)
containing varying concentrations of CaCl2 for 1 h at
4‡C. Mixtures were then centrifuged for 20 min at
150 000Ug to separate non-polymerized G-actin
from F-actin and bound proteins. Equivalent
amounts of the pellets were analyzed by SDS-
PAGE and the proteins present were Coomassie-
stained and quanti¢ed densitometrically.
3. Results
3.1. Recombinant expression and puri¢cation of
medaka annexins
The four medaka annexin cDNAs identi¢ed previ-
ously by hybridization cloning [14] were cloned into
a modi¢ed pET expression vector and expressed in
E. coli after induction of recombinant protein syn-
thesis by IPTG. Separation of the soluble protein
fraction from the insoluble pool reveals that max
1^3 are found in the soluble bacterial extracts,
whereas max 4 remained insoluble (not shown).
Treatment with 8 M urea, however, leads to a solu-
bilization of max 4 which subsequently can be rena-
tured by stepwise dilution and dialysis against urea-
free bu¡er.
The renatured max 4 as well as the soluble max
1^3 proteins were puri¢ed using a combination of
ion-exchange chromatography and Ca2-dependent
liposome pelleting. Fig. 1 shows that this protocols
yields essentially pure proteins with apparent molec-
ular masses corresponding to those predicted from
the deduced protein sequences. While all medaka
annexins identi¢ed contain a protein core composed
of four annexin repeats only max 1^3 fall in the 35-
kDa class of annexins characterized by a relatively
short N-terminal domain. Max 4 has an extended N-
terminal domain of 202 residues which is rich in gly-
cine, tyrosine and proline residues and responsible
for its somewhat larger apparent molecular mass of
approximately 53 kDa. It seems likely that this ex-
tended N-terminal domain is responsible for the in-
solubility of bacterially expressed max 4 as a trun-
cated max 4 lacking the N-terminal 201 residues is
recovered from the soluble bacterial lysate (data not
shown). Limited proteolysis was carried out to verify
that full-length max 4 puri¢ed from bacterial inclu-
sion bodies after urea solubilization has assumed the
correct conformation. Such experiments have been
widely used to de¢ne typical annexin core domains
as the cores are resistant to limited proteolytic diges-
tion [16,17]. Fig. 2 reveals that this is also observed
in the case of the recombinant max 4, indicating that
urea solubilization and subsequent renaturation do
not a¡ect the overall folding of the max 4 core do-
main. This had previously also been shown for the
annexin II core puri¢ed from bacterial inclusion
bodies [18].
3.2. Ca2+-dependent interaction of medaka annexins
with phospholipids and actin ¢laments
The biochemical hallmark of members of the an-
nexin family is their Ca2-regulated interaction with
negatively charged phospholipids which are enriched
Table 1
Ca2 concentrations required for half-maximal phospholipid binding and half-maximal vesicle aggregation by the four medaka annex-
ins
Protein [Ca2] at half-maximal phospholipid binding (WM) [Ca2] at half-maximal vesicle aggregation (WM)
max 1 20 þ 5 s 500
max 2 35 þ 5 110 þ 10
max 3 1.5 þ 0.5 10 þ 1.5
max 4 55 þ 10 65 þ 10
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in the cytosolic lea£ets of cellular membranes [9,10].
To verify whether this property is shared by the med-
aka annexins and to determine the Ca2 concentra-
tions required to trigger this activity, we performed a
series of phospholipid-binding experiments using a
phospholipid mixture from bovine brain (containing
primarily phosphatidylserine) as substrate. Phospho-
lipid liposomes of uniform size were mixed with the
individual medaka annexins puri¢ed as described
above. Reactions were carried out in the presence
of free Ca2 concentrations ranging from 1 to 500
WM and the amount of phospholipid bound annexin
was elucidated by liposome copelleting. Fig. 3 shows
the results for the individual medaka annexins and
reveals that all proteins are capable of interacting
with phospholipid liposomes in a Ca2-dependent
manner. However, signi¢cant di¡erences are evident
when the Ca2 concentrations required for half-max-
imal binding to the phospholipids are compared (Ta-
ble 1). While max 1, 2, and 4 require relatively high
Fig. 1. Puri¢cation of recombinantly expressed medaka annex-
ins. Max 1^4 were expressed in bacteria and puri¢ed from ei-
ther insoluble inclusion bodies (max 4) or the soluble bacterial
extract (max 1^3) as described in Section 2. Shown are SDS-
PAGE analyses of the di¡erent puri¢cation steps. (A) Puri¢ca-
tion of max 4. Bacteria expressing max 4 (a total cell extract is
shown in lane 2 as compared to a total extract from non-trans-
formed bacteria in lane 1) were lysed and the soluble proteins
(lane 3) were separated from insoluble material (lane 4) by cen-
trifugation. The insoluble fraction containing max 4 was
washed twice with detergent (the proteins present in the two
wash fractions are given in lanes 5 and 6) and then resuspended
in 8 M urea (lane 7). The urea-solubilized material was dialyzed
against urea-free bu¡er and renatured proteins were subjected
to ion-exchange chromatography (lane 8). Final puri¢cation of
max 4 was achieved by preparative liposome pelleting (lane 9).
(B) Puri¢cation of max 3 as an example for the medaka annex-
ins expressed as soluble proteins in the bacteria. A lysate con-
taining soluble proteins from bacteria expressing max 3 (lane 2;
a non-expressing culture is shown in lane 1) is shown in lane 3.
Max 3, present in this soluble pool, was puri¢ed by ion-ex-
change chromatography on DE-52 and S10-HyperD (lane 4)
and preparative liposome pelleting (lane 5). (C) Recombinantly
expressed max 1 (lane 1), max 2 (lane 2), max 3 (lane 3) and
max 4 (lane 4) after the ¢nal puri¢cation step.
6
Fig. 2. Limited proteolysis yields a stable max 4 core. Puri¢ed
max 4 was subjected to limited trypsin proteolysis at an enzyme
to substrate ratio of 1:80. Aliquots of the reaction were re-
moved after the times indicated and analyzed by SDS-PAGE.
Note the generation of a stable protein core of approximately
35 kDa which is the major protein species after 10 min of tryp-
sin treatment.
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Ca2 concentrations (20^55 WM) for half-maximal
binding, max 3 is capable of interacting with phos-
pholipids in a signi¢cant manner at much lower Ca2
levels. The 1.5 WM required for half-maximal lipo-
some binding are in line with what was previously
observed for mammalian annexin I [19] classi¢ed by
sequence comparison as the closest relative of max 3
in the annexin family [14].
Another property shared by some, but not all, an-
nexins is their ability to aggregate membrane vesicles
and arti¢cial liposomes and it is thought that this
property could play a role in the postulated function
in membrane tra⁄cking and/or membrane organiza-
tion [10]. Phospholipid vesicle aggregation by the
medaka annexins was analyzed by turbidity measure-
ments using again phospholipid liposomes of uni-
form size. The liposomes were mixed with the recom-
binantly expressed medaka annexins in the presence
of varying Ca2 concentrations and a potential tur-
bidity increase resulting from vesicle aggregation was
recorded spectrophotometrically. Fig. 4 reveals that
of all medaka annexins, only max 3 is able to induce
liposome aggregation at Ca2 concentrations occur-
ring in stimulated cells, e.g. vertebrate eggs after fer-
tilization. Although max 2 and 4 are also capable of
aggregating liposomes, the Ca2 concentrations re-
quired to trigger this activity are rather high, with
Fig. 3. Ca2-dependent phospholipid vesicle binding of the four
medaka annexins. The puri¢ed medaka annexins, max 1^4,
were mixed with liposomes prepared from bovine brain phos-
pholipids in the presence of varying concentrations of free Ca2
(see Section 2). Liposomes were then pelleted by centrifugation
and bound protein was visualized by SDS-PAGE of the pellet
fraction. The relevant parts of the SDS gels are shown for reac-
tions carried out at the Ca2 concentrations indicated. Note
that of all medaka annexins, only max 3 shows a signi¢cant lip-
osome binding at Ca2 levels in the low micromolar range.
Fig. 4. Phospholipid vesicle aggregation induced by medaka an-
nexins. Medaka annexins were mixed with phospholipid lipo-
somes in the presence of varying concentrations of free Ca2.
Vesicle aggregation induced by the medaka annexins was then
measured spectrophotometrically by recording the turbidity of
the liposome mixture at 450 nm. In all experiments the end-
point of the turbidity increase was reached after a maximum of
15 min (OD450; end). The turbidity of the liposomes without
medaka annexins was set arbitrarily to 0. Given are the end
values of the turbidity increases as (OD450; end3OD450; 0)/
OD450; 0 with OD450; 0 representing the turbidity of the lipo-
some mixture before the addition of annexins. Max 2 reprodu-
cibly induces a greater turbidity increase possibly by the forma-
tion of larger liposome^annexin aggregates. However, this is
only observed at relatively high Ca2 levels.
BBAMCR 14399 4-12-98
R. Spenneberg et al. / Biochimica et Biophysica Acta 1448 (1998) 311^319316
110 and 65 WM inducing half-maximal e¡ects in the
case of max 2 and 4, respectively (Table 1). While
vesicle aggregation has not been reported previously
for annexin IX, a mammalian relative of max 4, the
data for max 2 are in contrast to what has been
observed for mammalian annexin IV which although
closely related in sequence to max 2 appears incapa-
ble of aggregating phospholipid vesicles at the Ca2
concentrations employed here (for review on annexin
IV data see [9]. Under the conditions chosen in our
analysis max 1 does not induce phospholipid vesicle
aggregation (Fig. 4). This has also been observed for
mammalian annexin V [19] identi¢ed by sequence
comparison as the max 1 homolog [14].
To further characterize the medaka annexins, we
analyzed their ability to interact with actin ¢laments,
typical structures of the cortical cytoskeleton. F-actin
binding had been documented previously for annex-
ins I and II [20,21] and it had been proposed to
enable these annexins to link intracellular membrane
domains to the underlying actin cytoskeleton [10]. F-
actin ¢laments assembled from monomeric muscle
actin were mixed with the di¡erent medaka annexins
and binding to the ¢laments was monitored by a
cosedimentation assay. Fig. 5 reveals that only max
3 shows a signi¢cant binding to the actin ¢laments
and that this binding occurs Ca2-dependently
with 25 WM representing a threshold concentration.
Max 1, 2, and 4, on the other hand, are not able
to interact with F-actin in a signi¢cant manner.
This again supports the view that max 3 is a rela-
tive of mammalian annexin I whereas max 1, 2, and
4 are more closely related to other members of
the family (annexins V, IV and XI, respectively)
which most likely are also incapable of F-actin bind-
ing.
4. Discussion
The four medaka annexins, max 1^4, had previ-
ously been identi¢ed by hybridization cloning and
their RNA was shown to be present in di¡erent cell
types of di¡erent developmental stages [14]. Accord-
ing to sequence features, primarily of the N-terminal
domains, two of the medaka annexins, max 1 and 2,
were classi¢ed as homologs of mammalian annexins
V and IV, respectively, whereas the other two, max 3
and 4, appeared to be novel members of the family
most closely related to the mammalian annexins I or
II and XI, respectively. Our biochemical character-
ization now reveals that the proteins are not only
related by sequence to members of the annexin fam-
ily, but also share characteristic biochemical features.
While all are capable of binding to acidic phospho-
lipids in a Ca2-dependent manner characteristic dif-
ferences in the Ca2 sensitivities are observed. Of all
medaka annexins, only max 3 shows signi¢cant phos-
pholipid binding at submicromolar Ca2 levels with
a half-maximal binding occurring at 1.5 WM Ca2
(Fig. 3, Table 1). This value is in good agreement
with the Ca2 concentration required for half-maxi-
mal binding of mammalian annexin I to phosphati-
dylserine liposomes (for review see [9]). Furthermore,
like annexin I, max 3 is capable of aggregating phos-
pholipid liposomes at micromolar Ca2 levels (Fig. 4,
Table 1). These results identify annexin I as the clos-
est relative of max 3 within the annexin family, thus
supporting our classi¢cation according to sequence
features. In the case of max 1, the biochemical char-
acteristics are also in line with its sequence-based
classi¢cation as a homolog of mammalian annexin
V. Both require similar Ca2 levels for half-maximal
phospholipid binding and both are unable to induce
the aggregation of liposomes (see [9] for review on
annexin V data). In contrast, the biochemical proper-
ties of max 2 di¡er signi¢cantly from those of mam-
malian annexin IV previously thought to represent
its homolog on the basis of sequence features [14].
Fig. 5. Max 3 is capable of binding actin ¢laments. F-actin was
mixed with puri¢ed max 3 in the presence of the Ca2 concen-
trations indicated. Actin ¢laments were then collected by centri-
fugation and proteins in the pellet fractions were analyzed by
SDS-PAGE. Binding of max 3 as revealed by co-pelleting with
the actin ¢laments occurs at 25 WM Ca2.
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While max 2 requires 35 WM Ca2 for half-maximal
phospholipid binding (Table 1), annexin IV already
displays this activity at 2.4 WM Ca2 (see [9] for an
overview). Moreover, whereas annexin IV shows no
signi¢cant vesicle aggregation, max 2 is capable of
aggregating liposomes, albeit only at relatively high
Ca2 concentrations. Thus max 2 has properties dif-
fering from those of the known mammalian annexins
and it remains to be established whether its function
is restricted to certain aspects of ¢sh development/
egg fertilization. Similar to max 2, max 4 is a ¢sh
annexin capable of phospholipid binding and of in-
ducing vesicle aggregation at relatively high Ca2
levels. So far, such a biochemical characterization
has not been reported for its mammalian relative,
annexin XI. However, annexin VII, a member of
the family with an extended N-terminal domain sim-
ilarly rich in glycine, tyrosine and proline, displays
properties similar to those of max 4 in the assays
described [9].
Immunoblot analyses using a pan-annexin anti-
body as well as partial protein puri¢cation have re-
vealed the presence of ¢ve annexins in unfertilized
eggs of a di¡erent ¢sh species, the loach Misgurnus
fossilis [7]. Four of them most likely correspond to
the four medaka annexins characterized here, indi-
cating that a large number of di¡erent annexin pro-
teins is stored in the unfertilized ¢sh egg. The bio-
chemical properties of these annexins reported here
indicate that at least one of them, max 3, could be
involved in Ca2-regulated events leading to cortical
granule exocytosis following fertilization. Max 3 is
capable of binding to phospholipid membranes, e.g.
cortical granule membranes or the plasma mem-
brane, at micromolar Ca2 concentrations and more-
over can induce the aggregation of membrane
vesicles in the presence of micromolar Ca2 levels.
Thus it is tempting to speculate that max 3 upon
fertilization induced induction of a Ca2 transient
could aggregate cortical granules with one another
or with the egg plasma membrane. The vesicle at-
tachment is most likely a prerequisite of cortical
granule exocytosis and it remains possibly that max
3 cooperates with a SNARE machinery in Ca2-de-
pendently docking cortical granules at the plasma
membrane. Such activity has been proposed for
mammalian annexin II on the basis of experiments
in permeabilized chroma⁄n cells and patch-clamped
endothelial cells [11^13]. However, in the case of an-
nexin II, a function in Ca2-regulated exocytosis crit-
ically depends on its complex formation with the
S100A10 (p11) protein. Only the heterotetrameric
annexin II2p112 complex is capable of aggregating
lipid vesicles at physiologically relevant Ca2 concen-
trations (for review see [9]) and complex disruption
speci¢cally interferes with Ca2 triggered secretion at
least in endothelial cells [13]. It is interesting to note
that max 3 displays vesicle aggregation at micromo-
lar Ca2 levels already as a monomeric entity and
thus it remains possible that a role of the annexin
II^p11 complex in Ca2-regulated exocytosis in cer-
tain somatic cells is ful¢lled by monomeric max 3 in
fertilized eggs.
In addition to binding to and aggregating phos-
pholipid vesicles, max 3 is also capable of binding
actin ¢laments in a Ca2-regulated manner. This is
again reminiscent of what has been reported for
mammalian annexins I and II (for review see [10]).
Actin ¢laments are typical constituents of the cortical
cytoskeleton and are known to play a role in exocy-
tosis, e.g. since the actin network transiently depoly-
merizes during exocytosis and since actin ¢lament
disassembly is a su⁄cient ¢nal trigger for exocytosis
in non-excitable cells (see, for example, [22] and
references therein). On the other hand it appears
that exocytosis cannot occur without some actin cy-
toskeleton being present and it has been observed
that actin-based myosin motors are involved in a
fast step of Ca2-regulated exocytosis. These prob-
ably enable secretory vesicles to move along cortical
actin cables after a slow kinesin/microtubule-depend-
ent transport to the cell periphery [23]. Based on the
properties reported here for max 3, it represents a
candidate protein for docking vesicles, not only to
membrane surfaces, but also to such actin cables.
Future experiments, e.g. the generation of function
interfering antibodies directed against max 3 and
their injection into medaka eggs prior to fertilization,
have to reveal whether this annexin indeed plays a
role in the Ca2-triggered cortical granule exocytosis
and whether it provides physical linkage between
granules and the plasma membrane and/or between
granules and cortical actin ¢laments once Ca2 is
elevated.
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